PMID- 34085904
OWN - NLM
STAT- MEDLINE
DCOM- 20211025
LR  - 20240207
IS  - 2164-554X (Electronic)
IS  - 2164-5515 (Print)
IS  - 2164-5515 (Linking)
VI  - 17
IP  - 9
DP  - 2021 Sep 2
TI  - Trends in the rates of health-care providers' recommendation for HPV vaccine from 
      2012 to 2018: a multi-round cross-sectional analysis of the health information 
      national trends survey.
PG  - 3081-3089
LID - 10.1080/21645515.2021.1917235 [doi]
AB  - The 2012 report of the President's Cancer Panel highlighted the overriding 
      contribution of missed clinical opportunities to suboptimal HPV vaccination 
      coverage. Since then, it remains unknown whether the rates of provider 
      recommendations for the HPV vaccine in the US population have increased. We 
      conducted an analysis of four rounds of the Health Information National Trends 
      Survey (HINTS), a household survey of civilian US residents aged 18 y or older. A 
      total of 1,415 (2012), 1,476 (2014), 1,208 (2017), and 1,344 (2018) respondents 
      to the HINTS survey who were either HPV vaccine-eligible or living with HPV 
      vaccine-eligible individuals were included. Overall, the rates of providers' 
      recommendations remained stagnated from 2012 to 2018 in all categories of the 
      study population, except for non-Hispanic Blacks (NHBs), where this prevalence 
      increased during the study period (AAPC = 16.4%, p < .001). In vaccine-eligible 
      individuals (18-27 y), declining trends were noted overall (AAPC = -21.6%, p 
      < .001), among NHWs (AAPC = -30.2%, p < .001) and urban dwellers (AAPC = -21.4%, 
      p < .001). Among vaccine-ineligible respondents (>27 y) living with 
      vaccine-eligible individuals, trends in the prevalence of provider 
      recommendations for HPV vaccine were stagnating overall (AAPC = 0.5%, p = .90), 
      and increasing only among NHBs (AAPC = 13.9%, p < .001). Despite recent progress, 
      our findings indicate variations of trends in provider recommendations for the 
      HPV vaccine in the US adult population according to age, sex, race/ethnicity, and 
      residence. To accelerate HPV vaccination uptake, immediate actions to enhance 
      provider recommendation for HPV vaccine are needed.
FAU - Domgue, Joel Fokom
AU  - Domgue JF
AUID- ORCID: 0000-0002-4722-9262
AD  - Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 
      Houston, TX, USA.
AD  - Division of Cancer Prevention and Population Science, The University of Texas MD 
      Anderson Cancer Center, Houston, TX, USA.
AD  - Department of Gynecologic Oncology and Reproductive Medicine, The University of 
      Texas MD Anderson Cancer Center, Houston, TX, USA.
FAU - Yu, Robert K
AU  - Yu RK
FAU - Shete, Sanjay
AU  - Shete S
AUID- ORCID: 0000-0001-7622-376X
AD  - Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 
      Houston, TX, USA.
AD  - Division of Cancer Prevention and Population Science, The University of Texas MD 
      Anderson Cancer Center, Houston, TX, USA.
AD  - Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 
      Houston, TX, USA.
LA  - eng
GR  - P30 CA016672/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20210604
PL  - United States
TA  - Hum Vaccin Immunother
JT  - Human vaccines & immunotherapeutics
JID - 101572652
RN  - 0 (Papillomavirus Vaccines)
SB  - IM
MH  - Adult
MH  - Cross-Sectional Studies
MH  - Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - *Papillomavirus Infections/epidemiology/prevention & control
MH  - *Papillomavirus Vaccines
MH  - Surveys and Questionnaires
MH  - Vaccination
MH  - Vaccination Coverage
PMC - PMC8381778
OTO - NOTNLM
OT  - HPV vaccination
OT  - disparities
OT  - health information national trends survey
OT  - health-care provider recommendation
OT  - trends
COIS- No potential conflicts of interest were disclosed.
EDAT- 2021/06/05 06:00
MHDA- 2021/10/26 06:00
PMCR- 2022/06/04
CRDT- 2021/06/04 12:14
PHST- 2021/06/05 06:00 [pubmed]
PHST- 2021/10/26 06:00 [medline]
PHST- 2021/06/04 12:14 [entrez]
PHST- 2022/06/04 00:00 [pmc-release]
AID - 1917235 [pii]
AID - 10.1080/21645515.2021.1917235 [doi]
PST - ppublish
SO  - Hum Vaccin Immunother. 2021 Sep 2;17(9):3081-3089. doi: 
      10.1080/21645515.2021.1917235. Epub 2021 Jun 4.